Cited 0 time in
Which is better for Carbpaenem resistant Pseudomonas aerugiona infection? Ceftozolone-tazobactam versus Ceftazidime-avibactam
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 김봉영 | - |
| dc.date.accessioned | 2026-06-25T03:01:42Z | - |
| dc.date.available | 2026-06-25T03:01:42Z | - |
| dc.date.issued | 2025-11-07 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/215958 | - |
| dc.title | Which is better for Carbpaenem resistant Pseudomonas aerugiona infection? Ceftozolone-tazobactam versus Ceftazidime-avibactam | - |
| dc.type | Conference | - |
| dc.citation.conferenceName | 대한감염학회/대한항균요법학회 추계학술대회 | - |
| dc.citation.conferencePlace | 인천그랜드하얏트호텔 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
